RxDoctor Payments Data

Daniel Cabanero

Physician Assistant · Laguna Hills, CANPI 1801525472

Payments from drug & device makers

$2,894in general payments, 2019–2025

Across 95 payments — averaging $30.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$386
  • Teleflex LLC$278
  • Astellas Pharma US Inc$208
  • Coloplast$180
  • Blue Earth Diagnostics$177
  • Myriad Genetic Laboratories, Inc.$160
  • plus $2K from 21 others

What the payments were for

  • Food & beverage$2,66392%
  • Education$2318%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,894 in reported general payments places this provider in the 85th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron17$14,671
MyrbetriqMirabegron15$6,861
Testosterone20$3,849
Tamsulosin Hcl76$1,208
Testosterone Cypionate15$359
Finasteride26$329
Cefdinir15$186
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim32$166
Ciprofloxacin Hcl21$150
Doxycycline Hyclate11$122
Cephalexin21$90
Oxybutynin Chloride11$78

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$90$14,67117 claims
Astellas Pharma US IncMyrbetriq$208$6,86115 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Laguna Hills

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →